Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK/PD of Mycophenolate Mofetil in Kidney Transplant
NCT01292226Phase 2Completed
- Sponsor
- Roche
- Start
- Dec 2006
- Primary completion
- Sep 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of mycophenolate mofetil in kidney transplant rejection, sponsored by Roche. Primary endpoints: Percentage of Participants With Acute Rejection at 28 weeks, Time to Rejection at 28 weeks and 1 more. Started Dec 2006; status: completed.
02
Drugs
mycophenolate mofetil
03
Conditions
kidney transplant rejection
Beyond the preview
Go deeper on NCT01292226.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01292226.